Attovia Therapeutics
PrivateLast Round
Series C
Apr 15, 2025
Total Funding Raised
$315M
Company Overview
Attovia Therapeutics is a biotechnology company that develops precision biologics and multispecific therapeutics for immune-mediated diseases and oncology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Attovia Therapeutics Comparables
Compare Attovia Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Santa Ana Bio | 79% | |
| Bambusa Therapeutics | 79% | |
| Apogee Therapeutics | 77% | |
Attovia Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Apr 15, 2025 | ||||
| Series B | May 9, 2024 | ||||
| Series A | Feb 8, 2024 | ||||
| Series A | Jun 20, 2023 |
Key People
Founding team and executive leadership
Attovia Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EcoR1 Capital | Series C, Series B |
| Redmile Group | Series B |
| Mirae Asset | Series C |
| Cormorant Asset Management | Series C, Series B |
| Vida Ventures | Series C |
| Deep Track Capital | Series C |
| Frazier Life Sciences | Series C, Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 13, 2025
Partnered with SciNeuro Pharmaceuticals on a neurology target.
- Apr 15, 2025
$90M round raised.
Attovia Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Attovia Therapeutics's valuation, stock price, and market status.